---
accession : E-GEOD-48841
platform  : A-AFFY-44
pathway   : VEGF
cells     : primary cultured human lung endothelial cells
treatment : 50 ng/ml VEGF
effect    : activating
hours     : 1

control   :
    - GSM1185521 1
    - GSM1185522 1
    - GSM1185525 1
perturbed :
    - GSM1185526 1

---
accession : E-GEOD-48841
platform  : A-AFFY-44
pathway   : VEGF
cells     : primary cultured human lung endothelial cells
treatment : 50 ng/ml VEGF
effect    : activating
hours     : 4

control   :
    - GSM1185521 1
    - GSM1185522 1
    - GSM1185525 1
perturbed :
    - GSM1185527 1

---
accession : E-GEOD-48841
platform  : A-AFFY-44
pathway   : VEGF
cells     : primary cultured human lung endothelial cells
treatment : 50 ng/ml VEGF
effect    : activating
hours     : 24

control   :
    - GSM1185521 1
    - GSM1185522 1
    - GSM1185525 1
perturbed :
    - GSM1185528 1

---
accession : E-GEOD-48841
platform  : A-AFFY-44
pathway   : VEGF
cells     : primary cultured human lung endothelial cells, siDSCR1
treatment : 50 ng/ml VEGF
effect    : activating
hours     : 1

control   :
    - GSM1185523 1
    - GSM1185524 1
    - GSM1185529 1
perturbed :
    - GSM1185530 1

---
accession : E-GEOD-48841
platform  : A-AFFY-44
pathway   : VEGF
cells     : primary cultured human lung endothelial cells, siDSCR1
treatment : 50 ng/ml VEGF
effect    : activating
hours     : 4

control   :
    - GSM1185523 1
    - GSM1185524 1
    - GSM1185529 1
perturbed :
    - GSM1185531 1

---
accession : E-GEOD-48841
platform  : A-AFFY-44
pathway   : VEGF
cells     : primary cultured human lung endothelial cells, siDSCR1
treatment : 50 ng/ml VEGF
effect    : activating
hours     : 24

control   :
    - GSM1185523 1
    - GSM1185524 1
    - GSM1185529 1
perturbed :
    - GSM1185532 1
...
